BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer

J Cancer Res Clin Oncol. 2010 Aug;136(8):1293-4. doi: 10.1007/s00432-010-0922-8. Epub 2010 Jun 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / pathology*
  • ErbB Receptors / immunology*
  • Humans
  • Mutation*
  • Neoplasm Metastasis / genetics*
  • Proto-Oncogene Proteins B-raf / genetics*

Substances

  • Antibodies, Monoclonal
  • ErbB Receptors
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf